What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Myocardial infarction
The scientist’s investigation covers issues in Internal medicine, Cardiology, Atrial fibrillation, Stroke and Endocrinology.
His Cardiology research incorporates themes from Platelet aggregation inhibitor and Aspirin.
When carried out as part of a general Atrial fibrillation research project, his work on Cardioversion and Vitamin K antagonist is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His research in Cardioversion intersects with topics in Left atrial appendage occlusion and HAS-BLED.
His Stroke research is multidisciplinary, incorporating elements of Alternative medicine, Thrombosis, Surgery and Warfarin.
His work is dedicated to discovering how Management of atrial fibrillation, Catheter ablation are connected with Dronedarone and other disciplines.
His most cited work include:
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)
- Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2467 citations)
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation (2409 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Atrial fibrillation, Stroke and Endocrinology.
In his works, he conducts interdisciplinary research on Internal medicine and In patient.
The concepts of his Cardiology study are interwoven with issues in Thrombosis and Surgery.
Raffaele De Caterina frequently studies issues relating to Anesthesia and Atrial fibrillation.
His biological study spans a wide range of topics, including Apixaban, Randomized controlled trial and Hazard ratio.
Within one scientific family, he focuses on topics pertaining to Intensive care medicine under Aspirin, and may sometimes address concerns connected to Disease.
He most often published in these fields:
- Internal medicine (53.88%)
- Cardiology (36.43%)
- Atrial fibrillation (18.22%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (53.88%)
- Cardiology (36.43%)
- Atrial fibrillation (18.22%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cardiology, Atrial fibrillation, Stroke and Intensive care medicine.
His study in Heart failure, Coronary artery disease, Acute coronary syndrome, Percutaneous coronary intervention and Myocardial infarction is done as part of Internal medicine.
His Cardiology research includes themes of Diabetes mellitus, Randomized controlled trial and Hazard ratio.
Many of his research projects under Atrial fibrillation are closely connected to In patient with In patient, tying the diverse disciplines of science together.
The various areas that he examines in his Stroke study include Apixaban, Observational study, Clinical trial and Embolism.
His Intensive care medicine research incorporates elements of Aspirin, Disease, Incidence and Antithrombotic.
Between 2016 and 2021, his most popular works were:
- Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making. (251 citations)
- Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial (91 citations)
- Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events- E uropean R egistry in A trial F ibrillation) (84 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Myocardial infarction
Raffaele De Caterina mainly investigates Internal medicine, Atrial fibrillation, Cardiology, Stroke and Diabetes mellitus.
His study in Randomized controlled trial, Myocardial infarction, Retrospective cohort study, Incidence and Ticagrelor falls under the purview of Internal medicine.
His Atrial fibrillation research is multidisciplinary, incorporating perspectives in Hazard ratio and valvular heart disease.
His Cardiology study frequently involves adjacent topics like Shock.
The Stroke study which covers Apixaban that intersects with Anemia, Reduction, Proportional hazards model and Cerebral infarction.
His studies deal with areas such as Angiogenesis, HMGB1, Vascular permeability, Disease and Aquaporin as well as Diabetes mellitus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
